Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
INDUSTRY
×
Immunoproliferative Disorders
×
Clear all
Filters
3
NCT01277172
2011-01-14
TREND
Probiomed S.A. de C.V.
Phase 2/3
Unknown
54 enrolled